Penelope Ward
Keine laufenden Positionen mehr
Profil
Penelope Ward worked as a Principal at UCB SA, Head-Rheumatology & Clinical Development at Hoffmann-La Roche, Inc., Chief Medical Officer at NovImmune SA, Clinical Research Physician at Upjohn Laboratories LLC, and Chief Medical Officer at Glenmark Pharmaceuticals Europe Ltd.
She obtained an undergraduate degree from University College London.
Ehemalige bekannte Positionen von Penelope Ward
| Unternehmen | Position | Ende |
|---|---|---|
| UCB | Corporate Officer/Principal | - |
Glenmark Pharmaceuticals Europe Ltd.
 Glenmark Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals Europe Ltd. is a British pharmaceutical company that is discovering advanced therapies for dermatology, oncology, and inflammation. Founded in 2004, the company is based in Harrow, UK. Glenmark's R&D is committed to identifying products that fulfill unique and unmet medical needs. The company began its operations in the market of exporting branded formulations to countries and provides financial results, announcements, and reports for investors and shareholders. | Technik-/Wissenschafts-/F&E-Leiter | - |
Pharmacia Ltd.
 Pharmacia Ltd. Miscellaneous Commercial ServicesCommercial Services Pharmacia Ltd. provides business support services. The company is headquartered in Sandwich, the United Kingdom. | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
| Upjohn Laboratories LLC | Corporate Officer/Principal | 01.01.2008 |
Ausbildung von Penelope Ward
| University College London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| UCB | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
| Upjohn Laboratories LLC | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Pharmacia Ltd.
Pharmacia Ltd. Miscellaneous Commercial ServicesCommercial Services Pharmacia Ltd. provides business support services. The company is headquartered in Sandwich, the United Kingdom. | Commercial Services |
Glenmark Pharmaceuticals Europe Ltd.
Glenmark Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals Europe Ltd. is a British pharmaceutical company that is discovering advanced therapies for dermatology, oncology, and inflammation. Founded in 2004, the company is based in Harrow, UK. Glenmark's R&D is committed to identifying products that fulfill unique and unmet medical needs. The company began its operations in the market of exporting branded formulations to countries and provides financial results, announcements, and reports for investors and shareholders. | Health Technology |
